Walleye Capital
MED icon

Walleye Capital’s Medifast MED Stock Holding History

Walleye Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4K Buy
1,452
+1,451
+145,100% +$16.7K ﹤0.01% 4437
2026
Q1 		$10 Buy
+1
New +$11 ﹤0.01% 4312
2025
Q4 		– Sell
-29,940
Closed -$409K – 4905
2025
Q3 		$409K Sell
29,940
-8,154
-21% -$114K ﹤0.01% 2784
2025
Q2 		$535K Buy
38,094
+25,473
+202% +$335K ﹤0.01% 2590
2025
Q1 		$170K Buy
+12,621
New +$190K ﹤0.01% 3380
2024
Q4 		– Sell
-6,457
Closed -$124K – 5259
2024
Q3 		$124K Sell
6,457
-5,017
-44% -$96.7K ﹤0.01% 4300
2024
Q2 		$250K Sell
11,474
-25,176
-69% -$671K ﹤0.01% 4131
2024
Q1 		$1.4M Buy
+36,650
New +$1.78M ﹤0.01% 2263
2023
Q4 		– Sell
-3,377
Closed -$253K – 5287
2023
Q3 		$253K Sell
3,377
-5,724
-63% -$508K ﹤0.01% 3378
2023
Q2 		$839K Buy
+9,101
New +$810K ﹤0.01% 2000
2023
Q1 		– Sell
-1,071
Closed -$119K – 4201
2022
Q4 		$124K Sell
1,071
-19,234
-95% -$2.24M ﹤0.01% 2287
2022
Q3 		$2.2M Buy
+20,305
New +$2.91M 0.04% 506
2021
Q2 		– Sell
-1,482
Closed -$314K – 1447
2021
Q1 		$314K Buy
+1,482
New +$355K 0.02% 735
2020
Q4 		– Sell
-1,458
Closed -$240K – 1035
2020
Q3 		$240K Buy
+1,458
New +$240K 0.03% 561
2019
Q3 		– Sell
-240
Closed -$31K – 2108
2019
Q2 		$31K Buy
+240
New +$33.3K ﹤0.01% 1465

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Walleye Capital's MED Position: Q2 2026 in Review

Walleye Capital increased its Medifast (MED) stake by 145,100% in Q2 2026, buying an estimated $16.7K and bringing the position to 1,452 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4437.

Walleye Capital first reported a position in MED in Q2 2019 and has held it in 15 quarters since. The position peaked at $2.2M in Q3 2022. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Walleye Capital held 1,452 shares of Medifast worth $15.4K as of Q2 2026.
  • Walleye Capital bought 1,451 Medifast shares in Q2 2026, an estimated $16.7K.
  • Medifast made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4437 holding.
  • Walleye Capital first reported a position in Medifast in Q2 2019 and has held it in 15 quarters since.
  • Walleye Capital's Medifast position peaked at $2.2M in Q3 2022.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.